This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In Corporate Livewire‘s June 2013 Round Table “Biotech & Pharmaceutical,” Dr. Gregory Bell and other leading experts discuss changes and analyze the effects they will have in the industry.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comWe are delighted to share that Alisa Knapp, Chris Bakewell, Dan McGavock, Dave Duski, Erin Crockett, Greg Bell, Jim Donohue, Julia Rowe, Kim Schenk, Mike Tate,...
Infertility affects more than 17% of people of reproductive age globally, yet access to ART remains uneven and often out of reach.
Abhishek Kumar, Elaine Damato and Alice Kim present their poster titled “Staying Competitive in a Crowded Vaccines Market: Is There Room for a Third or Fourth...
Greg Bell is a panelist during the session titled “Navigating Life Sciences disputes. An arbitrator’s perspective.” For more information on this event, click...
